Cargando…

Stable enhancers are active in development, and fragile enhancers are associated with evolutionary adaptation

BACKGROUND: Despite continual progress in the identification and characterization of trait- and disease-associated variants that disrupt transcription factor (TF)-DNA binding, little is known about the distribution of TF binding deactivating mutations (deMs) in enhancer sequences. Here, we focus on...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shan, Kvon, Evgeny Z., Visel, Axel, Pennacchio, Len A., Ovcharenko, Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631995/
https://www.ncbi.nlm.nih.gov/pubmed/31307522
http://dx.doi.org/10.1186/s13059-019-1750-z
_version_ 1783435649586561024
author Li, Shan
Kvon, Evgeny Z.
Visel, Axel
Pennacchio, Len A.
Ovcharenko, Ivan
author_facet Li, Shan
Kvon, Evgeny Z.
Visel, Axel
Pennacchio, Len A.
Ovcharenko, Ivan
author_sort Li, Shan
collection PubMed
description BACKGROUND: Despite continual progress in the identification and characterization of trait- and disease-associated variants that disrupt transcription factor (TF)-DNA binding, little is known about the distribution of TF binding deactivating mutations (deMs) in enhancer sequences. Here, we focus on elucidating the mechanism underlying the different densities of deMs in human enhancers. RESULTS: We identify two classes of enhancers based on the density of nucleotides prone to deMs. Firstly, fragile enhancers with abundant deM nucleotides are associated with the immune system and regular cellular maintenance. Secondly, stable enhancers with only a few deM nucleotides are associated with the development and regulation of TFs and are evolutionarily conserved. These two classes of enhancers feature different regulatory programs: the binding sites of pioneer TFs of FOX family are specifically enriched in stable enhancers, while tissue-specific TFs are enriched in fragile enhancers. Moreover, stable enhancers are more tolerant of deMs due to their dominant employment of homotypic TF binding site (TFBS) clusters, as opposed to the larger-extent usage of heterotypic TFBS clusters in fragile enhancers. Notably, the sequence environment and chromatin context of the cognate motif, other than the motif itself, contribute more to the susceptibility to deMs of TF binding. CONCLUSIONS: This dichotomy of enhancer activity is conserved across different tissues, has a specific footprint in epigenetic profiles, and argues for a bimodal evolution of gene regulatory programs in vertebrates. Specifically encoded stable enhancers are evolutionarily conserved and associated with development, while differently encoded fragile enhancers are associated with the adaptation of species. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13059-019-1750-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6631995
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66319952019-07-25 Stable enhancers are active in development, and fragile enhancers are associated with evolutionary adaptation Li, Shan Kvon, Evgeny Z. Visel, Axel Pennacchio, Len A. Ovcharenko, Ivan Genome Biol Research BACKGROUND: Despite continual progress in the identification and characterization of trait- and disease-associated variants that disrupt transcription factor (TF)-DNA binding, little is known about the distribution of TF binding deactivating mutations (deMs) in enhancer sequences. Here, we focus on elucidating the mechanism underlying the different densities of deMs in human enhancers. RESULTS: We identify two classes of enhancers based on the density of nucleotides prone to deMs. Firstly, fragile enhancers with abundant deM nucleotides are associated with the immune system and regular cellular maintenance. Secondly, stable enhancers with only a few deM nucleotides are associated with the development and regulation of TFs and are evolutionarily conserved. These two classes of enhancers feature different regulatory programs: the binding sites of pioneer TFs of FOX family are specifically enriched in stable enhancers, while tissue-specific TFs are enriched in fragile enhancers. Moreover, stable enhancers are more tolerant of deMs due to their dominant employment of homotypic TF binding site (TFBS) clusters, as opposed to the larger-extent usage of heterotypic TFBS clusters in fragile enhancers. Notably, the sequence environment and chromatin context of the cognate motif, other than the motif itself, contribute more to the susceptibility to deMs of TF binding. CONCLUSIONS: This dichotomy of enhancer activity is conserved across different tissues, has a specific footprint in epigenetic profiles, and argues for a bimodal evolution of gene regulatory programs in vertebrates. Specifically encoded stable enhancers are evolutionarily conserved and associated with development, while differently encoded fragile enhancers are associated with the adaptation of species. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13059-019-1750-z) contains supplementary material, which is available to authorized users. BioMed Central 2019-07-15 /pmc/articles/PMC6631995/ /pubmed/31307522 http://dx.doi.org/10.1186/s13059-019-1750-z Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Li, Shan
Kvon, Evgeny Z.
Visel, Axel
Pennacchio, Len A.
Ovcharenko, Ivan
Stable enhancers are active in development, and fragile enhancers are associated with evolutionary adaptation
title Stable enhancers are active in development, and fragile enhancers are associated with evolutionary adaptation
title_full Stable enhancers are active in development, and fragile enhancers are associated with evolutionary adaptation
title_fullStr Stable enhancers are active in development, and fragile enhancers are associated with evolutionary adaptation
title_full_unstemmed Stable enhancers are active in development, and fragile enhancers are associated with evolutionary adaptation
title_short Stable enhancers are active in development, and fragile enhancers are associated with evolutionary adaptation
title_sort stable enhancers are active in development, and fragile enhancers are associated with evolutionary adaptation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631995/
https://www.ncbi.nlm.nih.gov/pubmed/31307522
http://dx.doi.org/10.1186/s13059-019-1750-z
work_keys_str_mv AT lishan stableenhancersareactiveindevelopmentandfragileenhancersareassociatedwithevolutionaryadaptation
AT kvonevgenyz stableenhancersareactiveindevelopmentandfragileenhancersareassociatedwithevolutionaryadaptation
AT viselaxel stableenhancersareactiveindevelopmentandfragileenhancersareassociatedwithevolutionaryadaptation
AT pennacchiolena stableenhancersareactiveindevelopmentandfragileenhancersareassociatedwithevolutionaryadaptation
AT ovcharenkoivan stableenhancersareactiveindevelopmentandfragileenhancersareassociatedwithevolutionaryadaptation